428 related articles for article (PubMed ID: 9118530)
1. Angiotensin AT1 receptor inhibition. Effects on hypertrophic remodeling and ACE expression in rats with pressure-overload hypertrophy due to ascending aortic stenosis.
Weinberg EO; Lee MA; Weigner M; Lindpaintner K; Bishop SP; Benedict CR; Ho KK; Douglas PS; Chafizadeh E; Lorell BH
Circulation; 1997 Mar; 95(6):1592-600. PubMed ID: 9118530
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis.
Weinberg EO; Schoen FJ; George D; Kagaya Y; Douglas PS; Litwin SE; Schunkert H; Benedict CR; Lorell BH
Circulation; 1994 Sep; 90(3):1410-22. PubMed ID: 8087951
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II subtype-1 receptor blockade during the development of left ventricular hypertrophy in dogs: effects on ventricular and myocyte function.
Spinale FG; Holzgrefe HH; Walker JD; Mukherjee R; Kribbs SB; Powell JR; Antonaccio M
J Cardiovasc Pharmacol; 1997 Nov; 30(5):623-31. PubMed ID: 9388045
[TBL] [Abstract][Full Text] [Related]
4. Distribution and functional significance of cardiac angiotensin converting enzyme in hypertrophied rat hearts.
Schunkert H; Jackson B; Tang SS; Schoen FJ; Smits JF; Apstein CS; Lorell BH
Circulation; 1993 Apr; 87(4):1328-39. PubMed ID: 8384939
[TBL] [Abstract][Full Text] [Related]
5. Simvastatin inhibits cardiac hypertrophy and angiotensin-converting enzyme activity in rats with aortic stenosis.
Luo JD; Zhang WW; Zhang GP; Guan JX; Chen X
Clin Exp Pharmacol Physiol; 1999 Nov; 26(11):903-8. PubMed ID: 10561812
[TBL] [Abstract][Full Text] [Related]
6. Chronic L-arginine treatment increases cardiac cyclic guanosine 5'-monophosphate in rats with aortic stenosis: effects on left ventricular mass and beta-adrenergic contractile reserve.
Bartunek J; Dempsey S; Weinberg EO; Ito N; Tajima M; Rohrbach S; Lorell BH
J Am Coll Cardiol; 1998 Aug; 32(2):528-35. PubMed ID: 9708487
[TBL] [Abstract][Full Text] [Related]
7. Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy. Chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure.
Litwin SE; Katz SE; Weinberg EO; Lorell BH; Aurigemma GP; Douglas PS
Circulation; 1995 May; 91(10):2642-54. PubMed ID: 7743628
[TBL] [Abstract][Full Text] [Related]
8. Regulation of extracellular matrix proteins in pressure-overload cardiac hypertrophy: effects of angiotensin converting enzyme inhibition.
Grimm D; Kromer EP; Böcker W; Bruckschlegel G; Holmer SR; Riegger GA; Schunkert H
J Hypertens; 1998 Sep; 16(9):1345-55. PubMed ID: 9746122
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II type 2 receptor blockade partially negates antihypertrophic effects of type 1 receptor blockade on pressure-overload rat cardiac hypertrophy.
Mukawa H; Toki Y; Miyazaki Y; Matsui H; Okumura K; Ito T
Hypertens Res; 2003 Jan; 26(1):89-95. PubMed ID: 12661917
[TBL] [Abstract][Full Text] [Related]
10. Reciprocal regulation of pulmonary and cardiac angiotensin-converting enzyme in rats with severe left ventricular hypertrophy.
Pfeifer M; Bruckschlegel G; Holmer SR; Paul M; Riegger AJ; Schunkert H
Cardiovasc Res; 1998 Apr; 38(1):125-32. PubMed ID: 9683914
[TBL] [Abstract][Full Text] [Related]
11. Effects of losartan, an angiotensin II antagonist, on the development of cardiac hypertrophy due to volume overload.
Ishiye M; Umemura K; Uematsu T; Nakashima M
Biol Pharm Bull; 1995 May; 18(5):700-4. PubMed ID: 7492986
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in the angiotensinogen and angiotensin II type 1 receptor gene are related to change in left ventricular mass during antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial.
Kurland L; Melhus H; Karlsson J; Kahan T; Malmqvist K; Ohman P; Nyström F; Hägg A; Lind L
J Hypertens; 2002 Apr; 20(4):657-63. PubMed ID: 11910301
[TBL] [Abstract][Full Text] [Related]
13. Roles of renin-angiotensin and endothelin systems in development of diastolic heart failure in hypertensive hearts.
Yamamoto K; Masuyama T; Sakata Y; Mano T; Nishikawa N; Kondo H; Akehi N; Kuzuya T; Miwa T; Hori M
Cardiovasc Res; 2000 Aug; 47(2):274-83. PubMed ID: 10946064
[TBL] [Abstract][Full Text] [Related]
14. Role of neurohumoral systems for pressure induced left ventricular hypertrophy in experimental supravalvular aortic stenosis in rats.
Kromer EP; Elsner D; Riegger GA
Am J Hypertens; 1991 Jun; 4(6):521-4. PubMed ID: 1678610
[TBL] [Abstract][Full Text] [Related]
15. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat.
Schieffer B; Wirger A; Meybrunn M; Seitz S; Holtz J; Riede UN; Drexler H
Circulation; 1994 May; 89(5):2273-82. PubMed ID: 8181153
[TBL] [Abstract][Full Text] [Related]
16. Distribution and function of cardiac angiotensin AT1- and AT2-receptor subtypes in hypertrophied rat hearts.
Lopez JJ; Lorell BH; Ingelfinger JR; Weinberg EO; Schunkert H; Diamant D; Tang SS
Am J Physiol; 1994 Aug; 267(2 Pt 2):H844-52. PubMed ID: 8067441
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin AT1 receptor-mediated attenuation of cardiac hypertrophy due to volume overload: involvement of endothelin.
Ishiye M; Umemura K; Uematsu T; Nakashima M
Eur J Pharmacol; 1995 Jun; 280(1):11-7. PubMed ID: 7498249
[TBL] [Abstract][Full Text] [Related]
18. Effects of quinapril on expression of eNOS, ACE, and AT1 receptor in deoxycorticosterone acetate-salt hypertensive rats.
Hara K; Kobayashi N; Watanabe S; Tsubokou Y; Matsuoka H
Am J Hypertens; 2001 Apr; 14(4 Pt 1):321-30. PubMed ID: 11336177
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro.
Kojima M; Shiojima I; Yamazaki T; Komuro I; Zou Z; Wang Y; Mizuno T; Ueki K; Tobe K; Kadowaki T
Circulation; 1994 May; 89(5):2204-11. PubMed ID: 8181146
[TBL] [Abstract][Full Text] [Related]
20. Effect of dual angiotensin converting enzyme/neutral endopeptidase inhibition, angiotensin converting enzyme inhibition, or AT1 antagonism on coronary microvasculature in spontaneously hypertensive rats.
Pu Q; Larouche I; Schiffrin EL
Am J Hypertens; 2003 Nov; 16(11 Pt 1):931-7. PubMed ID: 14573331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]